Gushengtang (HKG:2273) attributable profit rose to 306.8 million yuan in 2024 from 252.2 million yuan in 2023.
Earnings per share at the traditional Chinese medicine manufacturer increased to 1.22 yuan from 1.03 yuan in the previous year, according to a Monday filing with the Hong Kong bourse.
Revenue grew 30% to 3.02 billion yuan from 2.32 billion yuan a year earlier.
The company declared a final dividend of HK$0.41 per share, payable July 11 to shareholders on record as of June 30.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.